世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diagnosis of Autoimmune Diseases Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4125
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、自己免疫疾患診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（日常臨床検査、炎症マーカー、自己抗体＆免疫学検査、その他検査）、用途別市場規模（関節リウマチ、全身性エリテマトーデス、シェーグレン症候群、甲状腺炎、強皮症、その他疾患）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・自己免疫疾患診断の市場動向
・企業の競争状況、市場シェア
・自己免疫疾患診断の種類別市場規模と予測2016-2027（日常臨床検査、炎症マーカー、自己抗体＆免疫学検査、その他検査）
・自己免疫疾患診断の用途別市場規模と予測2016-2027（関節リウマチ、全身性エリテマトーデス、シェーグレン症候群、甲状腺炎、強皮症、その他疾患）
・自己免疫疾患診断の北米市場規模2016-2027（アメリカ、カナダ）
・自己免疫疾患診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己免疫疾患診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己免疫疾患診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己免疫疾患診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Thermo Fisher Scientific、Siemens、Inova Diagnostics、GRIFOLS、Danaher、Bio-Rad Laboratories、Abbott、Trinity Biotech、Werfen、Protagen、HYCOR Biomedical、HTG Molecular Diagnostics、EUROIMMUN AG）
・結論

Market Analysis and Insights: Global Diagnosis of Autoimmune Diseases Market
The global Diagnosis of Autoimmune Diseases market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnosis of Autoimmune Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnosis of Autoimmune Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnosis of Autoimmune Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnosis of Autoimmune Diseases market.

Global Diagnosis of Autoimmune Diseases Scope and Market Size
Diagnosis of Autoimmune Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnosis of Autoimmune Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies & Immunologic Test
Other Tests

Segment by Application
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Sjögren’s Syndrome
Thyroiditis
Scleroderma
Other Diseases

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
Siemens
Inova Diagnostics
GRIFOLS
Danaher
Bio-Rad Laboratories
Abbott
Trinity Biotech
Werfen
Protagen
HYCOR Biomedical
HTG Molecular Diagnostics
EUROIMMUN AG

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Routine Laboratory Tests
1.2.3 Inflammatory Markers
1.2.4 Autoantibodies & Immunologic Test
1.2.5 Other Tests
1.3 Market by Application
1.3.1 Global Diagnosis of Autoimmune Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Sjögren’s Syndrome
1.3.5 Thyroiditis
1.3.6 Scleroderma
1.3.7 Other Diseases
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diagnosis of Autoimmune Diseases Market Perspective (2016-2027)
2.2 Diagnosis of Autoimmune Diseases Growth Trends by Regions
2.2.1 Diagnosis of Autoimmune Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diagnosis of Autoimmune Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Diagnosis of Autoimmune Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Diagnosis of Autoimmune Diseases Industry Dynamic
2.3.1 Diagnosis of Autoimmune Diseases Market Trends
2.3.2 Diagnosis of Autoimmune Diseases Market Drivers
2.3.3 Diagnosis of Autoimmune Diseases Market Challenges
2.3.4 Diagnosis of Autoimmune Diseases Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue
3.1.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue (2016-2021)
3.1.2 Global Diagnosis of Autoimmune Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Diagnosis of Autoimmune Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diagnosis of Autoimmune Diseases Revenue
3.4 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio
3.4.1 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnosis of Autoimmune Diseases Revenue in 2020
3.5 Diagnosis of Autoimmune Diseases Key Players Head office and Area Served
3.6 Key Players Diagnosis of Autoimmune Diseases Product Solution and Service
3.7 Date of Enter into Diagnosis of Autoimmune Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnosis of Autoimmune Diseases Breakdown Data by Type
4.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Type (2016-2021)
4.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2022-2027)

5 Diagnosis of Autoimmune Diseases Breakdown Data by Application
5.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Application (2016-2021)
5.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diagnosis of Autoimmune Diseases Market Size (2016-2027)
6.2 North America Diagnosis of Autoimmune Diseases Market Size by Type
6.2.1 North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
6.2.2 North America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
6.2.3 North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
6.3 North America Diagnosis of Autoimmune Diseases Market Size by Application
6.3.1 North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
6.3.2 North America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
6.3.3 North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
6.4 North America Diagnosis of Autoimmune Diseases Market Size by Country
6.4.1 North America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
6.4.2 North America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Diagnosis of Autoimmune Diseases Market Size (2016-2027)
7.2 Europe Diagnosis of Autoimmune Diseases Market Size by Type
7.2.1 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
7.2.2 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
7.2.3 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
7.3 Europe Diagnosis of Autoimmune Diseases Market Size by Application
7.3.1 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
7.3.2 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
7.3.3 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
7.4 Europe Diagnosis of Autoimmune Diseases Market Size by Country
7.4.1 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
7.4.2 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size (2016-2027)
8.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type
8.2.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application
8.3.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region
8.4.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diagnosis of Autoimmune Diseases Market Size (2016-2027)
9.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Type
9.2.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
9.2.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
9.2.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
9.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Application
9.3.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
9.4 Latin America Diagnosis of Autoimmune Diseases Market Size by Country
9.4.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size (2016-2027)
10.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type
10.2.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application
10.3.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country
10.4.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Introduction
11.1.4 Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Diagnosis of Autoimmune Diseases Introduction
11.2.4 Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.2.5 Siemens Recent Development
11.3 Inova Diagnostics
11.3.1 Inova Diagnostics Company Details
11.3.2 Inova Diagnostics Business Overview
11.3.3 Inova Diagnostics Diagnosis of Autoimmune Diseases Introduction
11.3.4 Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.3.5 Inova Diagnostics Recent Development
11.4 GRIFOLS
11.4.1 GRIFOLS Company Details
11.4.2 GRIFOLS Business Overview
11.4.3 GRIFOLS Diagnosis of Autoimmune Diseases Introduction
11.4.4 GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.4.5 GRIFOLS Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Diagnosis of Autoimmune Diseases Introduction
11.5.4 Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.5.5 Danaher Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Introduction
11.6.4 Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Diagnosis of Autoimmune Diseases Introduction
11.7.4 Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Diagnosis of Autoimmune Diseases Introduction
11.8.4 Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.8.5 Trinity Biotech Recent Development
11.9 Werfen
11.9.1 Werfen Company Details
11.9.2 Werfen Business Overview
11.9.3 Werfen Diagnosis of Autoimmune Diseases Introduction
11.9.4 Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.9.5 Werfen Recent Development
11.10 Protagen
11.10.1 Protagen Company Details
11.10.2 Protagen Business Overview
11.10.3 Protagen Diagnosis of Autoimmune Diseases Introduction
11.10.4 Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.10.5 Protagen Recent Development
11.11 HYCOR Biomedical
11.11.1 HYCOR Biomedical Company Details
11.11.2 HYCOR Biomedical Business Overview
11.11.3 HYCOR Biomedical Diagnosis of Autoimmune Diseases Introduction
11.11.4 HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.11.5 HYCOR Biomedical Recent Development
11.12 HTG Molecular Diagnostics
11.12.1 HTG Molecular Diagnostics Company Details
11.12.2 HTG Molecular Diagnostics Business Overview
11.12.3 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Introduction
11.12.4 HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.12.5 HTG Molecular Diagnostics Recent Development
11.13 EUROIMMUN AG
11.13.1 EUROIMMUN AG Company Details
11.13.2 EUROIMMUN AG Business Overview
11.13.3 EUROIMMUN AG Diagnosis of Autoimmune Diseases Introduction
11.13.4 EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
11.13.5 EUROIMMUN AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Routine Laboratory Tests
Table 3. Key Players of Inflammatory Markers
Table 4. Key Players of Autoantibodies & Immunologic Test
Table 5. Key Players of Other Tests
Table 6. Global Diagnosis of Autoimmune Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diagnosis of Autoimmune Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diagnosis of Autoimmune Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2016-2021)
Table 10. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2022-2027)
Table 12. Diagnosis of Autoimmune Diseases Market Trends
Table 13. Diagnosis of Autoimmune Diseases Market Drivers
Table 14. Diagnosis of Autoimmune Diseases Market Challenges
Table 15. Diagnosis of Autoimmune Diseases Market Restraints
Table 16. Global Diagnosis of Autoimmune Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diagnosis of Autoimmune Diseases Market Share by Players (2016-2021)
Table 18. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2020)
Table 19. Ranking of Global Top Diagnosis of Autoimmune Diseases Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diagnosis of Autoimmune Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diagnosis of Autoimmune Diseases Product Solution and Service
Table 23. Date of Enter into Diagnosis of Autoimmune Diseases Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2016-2021)
Table 27. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diagnosis of Autoimmune Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2016-2021)
Table 31. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Product
Table 66. Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Development
Table 68. Siemens Company Details
Table 69. Siemens Business Overview
Table 70. Siemens Diagnosis of Autoimmune Diseases Product
Table 71. Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 72. Siemens Recent Development
Table 73. Inova Diagnostics Company Details
Table 74. Inova Diagnostics Business Overview
Table 75. Inova Diagnostics Diagnosis of Autoimmune Diseases Product
Table 76. Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 77. Inova Diagnostics Recent Development
Table 78. GRIFOLS Company Details
Table 79. GRIFOLS Business Overview
Table 80. GRIFOLS Diagnosis of Autoimmune Diseases Product
Table 81. GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 82. GRIFOLS Recent Development
Table 83. Danaher Company Details
Table 84. Danaher Business Overview
Table 85. Danaher Diagnosis of Autoimmune Diseases Product
Table 86. Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 87. Danaher Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Product
Table 91. Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Abbott Company Details
Table 94. Abbott Business Overview
Table 95. Abbott Diagnosis of Autoimmune Diseases Product
Table 96. Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 97. Abbott Recent Development
Table 98. Trinity Biotech Company Details
Table 99. Trinity Biotech Business Overview
Table 100. Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 101. Trinity Biotech Recent Development
Table 102. Werfen Company Details
Table 103. Werfen Business Overview
Table 104. Werfen Diagnosis of Autoimmune Diseases Product
Table 105. Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 106. Werfen Recent Development
Table 107. Protagen Company Details
Table 108. Protagen Business Overview
Table 109. Protagen Diagnosis of Autoimmune Diseases Product
Table 110. Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 111. Protagen Recent Development
Table 112. HYCOR Biomedical Company Details
Table 113. HYCOR Biomedical Business Overview
Table 114. HYCOR Biomedical Diagnosis of Autoimmune Diseases Product
Table 115. HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 116. HYCOR Biomedical Recent Development
Table 117. HTG Molecular Diagnostics Company Details
Table 118. HTG Molecular Diagnostics Business Overview
Table 119. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Product
Table 120. HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 121. HTG Molecular Diagnostics Recent Development
Table 122. EUROIMMUN AG Company Details
Table 123. EUROIMMUN AG Business Overview
Table 124. EUROIMMUN AG Diagnosis of Autoimmune Diseases Product
Table 125. EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
Table 126. EUROIMMUN AG Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnosis of Autoimmune Diseases Market Share by Type: 2020 VS 2027
Figure 2. Routine Laboratory Tests Features
Figure 3. Inflammatory Markers Features
Figure 4. Autoantibodies & Immunologic Test Features
Figure 5. Other Tests Features
Figure 6. Global Diagnosis of Autoimmune Diseases Market Share by Application: 2020 VS 2027
Figure 7. Rheumatoid Arthritis Case Studies
Figure 8. Systemic Lupus Erythematosus Case Studies
Figure 9. Sjögren’s Syndrome Case Studies
Figure 10. Thyroiditis Case Studies
Figure 11. Scleroderma Case Studies
Figure 12. Other Diseases Case Studies
Figure 13. Diagnosis of Autoimmune Diseases Report Years Considered
Figure 14. Global Diagnosis of Autoimmune Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Diagnosis of Autoimmune Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Diagnosis of Autoimmune Diseases Market Share by Regions: 2020 VS 2027
Figure 17. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2022-2027)
Figure 18. Global Diagnosis of Autoimmune Diseases Market Share by Players in 2020
Figure 19. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Diagnosis of Autoimmune Diseases Revenue in 2020
Figure 21. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2016-2021)
Figure 22. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2022-2027)
Figure 23. North America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
Figure 25. North America Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
Figure 26. North America Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
Figure 27. United States Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
Figure 31. Europe Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
Figure 32. Europe Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
Figure 33. Germany Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Region (2016-2027)
Figure 43. China Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
Figure 51. Latin America Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
Figure 52. Latin America Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
Figure 53. Mexico Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
Figure 59. Turkey Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 63. Siemens Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 64. Inova Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 65. GRIFOLS Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 66. Danaher Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 69. Trinity Biotech Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 70. Werfen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 71. Protagen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 72. HYCOR Biomedical Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 73. HTG Molecular Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 74. EUROIMMUN AG Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己免疫疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Drug Market Size, Status and Forecast 2021-2027
QFJ1-5604 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、自己免疫疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、抗炎症、インターフェロン、抗高血糖、その他）、用途別市場規模（関節リウマチ、1型糖尿病、多発性硬化症、乾癬、狼瘡、炎症性腸...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の自己免疫性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3872 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、自己免疫性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の臨床診断自動化市場規模・現状・予測（2021年-2027年）

Global Clinical Diagnosis Automation Market Size, Status and Forecast 2021-2027
QFJ1-4026 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、臨床診断自動化の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モジュール式自動化、総合式ラボ自動化）、用途別市場規模（病院、研究開発研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の結核分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Tuberculosis Market Size, Status and Forecast 2021-2027
QFJ1-4523 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、結核分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメ...

世界の精巣がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Testicular Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4522 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、精巣がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の自己免疫性溶血性貧血治療薬市場規模・現状・予測（2021年-2027年）

Global Autoimmune Hemolytic Anemia Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3871 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、自己免疫性溶血性貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北...

世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Myelodysplastic Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4519 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、骨髄異形成症候群分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模...

世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Hereditary Colorectal Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4518 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、遺伝性大腸がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（...

世界の熱帯性痙性対麻痺診断市場規模・現状・予測（2021年-2027年）

Global Tropical Spastic Paraparesis Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4984 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、熱帯性痙性対麻痺診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MRI、腰椎穿刺）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の全身性エリテマトーデス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Lupus Erythematosus Treatment Market The global Systemic Lupus Erythematosus Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
世界の全身性炎症反応症候群治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Inflammatory Response Syndrome Treatment Market The global Systemic Inflammatory Response Syndrome Treatment market size is projected to reach US$ 11740 million by 2027, from US$ 8346.7 million in 2020, at a CAGR of 4.5% during 2021-2027. With industry-s…
世界の自己免疫疾患治療薬市場規模・現状・予測（2021年-2027年） Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well …
世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …
世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Lupus Erythematosus (CLE) Treatment Market The global Cutaneous Lupus Erythematosus (CLE) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…